Page 15 - Steven Pergam News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2nd COVID-19 vaccine set for OK in US with panel endorsement | News, Sports, Jobs

Dec 18, 2020 WASHINGTON (AP) A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign. The Food and Drug Administration is expected to follow the recommendation for the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up. The FDA’s green light for emergency use is expected quickly. Moderna would then begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.

United statesModerna millerSteven pergamJacqueline millerScience departmentSeattle cancer care allianceNational institutes of healthHayley gans of stanford university medical centerDrug administrationStanford universityNational institutesHayley gansStanford university medicalOperation warp speedSeattle cancer careAssociated press health

Moderna COVID-19 vaccine set for OK in US with panel endorsement

Moderna COVID-19 vaccine set for OK in US with panel endorsement
newsday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.com Daily Mail and Mail on Sunday newspapers.

United statesModerna millerSteven pergamJacqueline millerSeattle cancer care allianceNational institutes of healthHayley gans of stanford university medical centerDrug administrationStanford universityNational institutesHayley gansStanford university medicalOperation warp speedSeattle cancer careஒன்றுபட்டது மாநிலங்களில்மாடர்னா மில்லர்

Moderna s coronavirus vaccine expected to get FDA approval Friday; shipments could start this weekend

Moderna s coronavirus vaccine expected to get FDA approval Friday; shipments could start this weekend
nola.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nola.com Daily Mail and Mail on Sunday newspapers.

United statesAlex azarModerna millerSteven pergamStephen hahnArnold montoSteven goodmanJacqueline millerHuman servicesNational institutes of healthDrug administrationUniversity of michiganSeattle cancer care allianceHayley gans of stanford university medical centerStanford universityNational institutes

Moderna COVID-19 vaccine set for OK in U S with panel endorsement

Published Thursday, December 17, 2020 5:45PM EST WASHINGTON - The head of the Food and Drug Administration said late Thursday that his agency will move to quickly authorize the second COVID-19 vaccine to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel. FDA Commissioner Stephen Hahn said in a statement that regulators have communicated their plans to drugmaker Moderna, which co-developed the vaccine with the National Institutes of Health. The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18 years old and up.

United statesModerna millerSteven pergamArnold montoSteven goodmanJacqueline millerSeattle cancer care allianceNational institutes of healthHayley gans of stanford university medical centerDrug administrationStanford universityUniversity of michiganNational institutesHayley gansStanford university medicalOperation warp speed

USFDA Moderna second COVID 19 vaccine panel endorsement coronavirus

URL copied Image Source : AP A second COVID-19 vaccine moved closer to joining the US fight against the pandemic on Thursday as government experts convened for a final public review of its safety and effectiveness. The head of the Food and Drug Administration said late Thursday that his agency will move to quickly authorize the second COVID-19 vaccine to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel. FDA Commissioner Stephen Hahn said in a statement that regulators have communicated their plans to drugmaker Moderna, which co-developed the vaccine with the National Institutes of Health. The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18 years old and up.

United statesModerna millerSteven pergamStephen hahnArnold montoSteven goodmanJacqueline millerSeattle cancer care allianceNational institutes of healthHayley gans of stanford university medical centerDrug administrationStanford universityUniversity of michiganImage sourceNational institutesHayley gans